PER 1.27% 8.0¢ percheron therapeutics limited

For General Information, page-1721

  1. 4,144 Posts.
    lightbulb Created with Sketch. 1916
    Well Arjay

    as i have already said i would be hoping for something along the lines of



    OUTSTANDING RESULTS IN COMBINATION TRIAL WITH REGARDS TO DYSTROPHIN RESTORATION

    blah blah blah Distrophyn has improved above and beyond the singular results and therefor we look forwards to taking this into human trials in the very near future, upon securing funding which was pending this positive outcome from the drill down into dystrophin restoration

    the market will be updated shortly with regards to trial design and funding arrangemets

    If this is not forthcoming within the same Ann

    IE plans to move forwards with funds attached then to me it will look like the same old same old

    Success once more with no hope of taking it any further due to funding restrictions so park it with the rest of our succesful trial outcomes sat awaiting funds to advance them

    I will have expected AF to have come up with something in the 6 months being April as a paid employer whose sole aim is to do exactly this, find funding to advance our programmes

    my fingers are crossed mate trust me i want success as much as the next man

    and just to touch on that i will say this of Mark Diamond he did say to me in conversation Sam although we dont always see eye to eye and our thoughts dont always align .

    One thing we both have in common, is to see the company succeed

    so see how we go arjay
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.